RVL Pharmaceuticals plc Quarterly Return On Assets in % from Q2 2019 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
RVL Pharmaceuticals plc quarterly/annual Return On Assets history and growth rate from Q2 2019 to Q2 2023.
  • RVL Pharmaceuticals plc Return On Assets for the quarter ending June 30, 2023 was -56.8 %, a 31.6% decline year-over-year.
  • RVL Pharmaceuticals plc annual Return On Assets for 2022 was -37.4 %, a 36% decline from 2021.
  • RVL Pharmaceuticals plc annual Return On Assets for 2021 was -27.5 %, a 50% decline from 2020.
  • RVL Pharmaceuticals plc annual Return On Assets for 2020 was -18.3 %, a 59.8% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -56.8 -13.7 -31.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.5 -9.59 -28.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -37.4 -9.89 -36% Oct 1, 2022 Dec 31, 2022
Q3 2022 -37.3 -3.12 -9.13% Jul 1, 2022 Sep 30, 2022
Q2 2022 -43.2 -18.8 -76.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -33.9 -12.6 -58.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -27.5 -9.16 -50% Oct 1, 2021 Dec 31, 2021
Q3 2021 -34.2 -23 -204% Jul 1, 2021 Sep 30, 2021
Q2 2021 -24.4 +8.39 +25.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -21.3 +30.2 +58.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -18.3 +27.3 +59.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -11.2 +40.6 +78.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -32.8 -1.66 -5.33% Apr 1, 2020 Jun 30, 2020
Q1 2020 -51.5 Jan 1, 2020 Mar 31, 2020
Q4 2019 -45.6 Oct 1, 2019 Dec 31, 2019
Q3 2019 -51.9 Jul 1, 2019 Sep 30, 2019
Q2 2019 -31.2 Apr 1, 2019 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.